For parents and families of children with neurodevelopmental conditions, the journey often begins with a search for answers. Conditions like Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD), and Schizophrenia (SCZ) affect how the brain develops and functions. Because these conditions are complex, finding clear markers early in life is a major goal for researchers who want to understand how genetics and environment interact from the very start of life.
To explore this, researchers looked at data from over 5,800 people across four different groups in Europe. They used something called polygenic scores (PGS). Think of these as a way to measure a person's genetic risk for a condition based on many different genes working together. They compared these genetic scores against patterns found in cord blood DNA methylation. Methylation is a chemical change that happens to DNA; it acts like a switch that can turn genes on or off. By looking at these two things together, they hoped to see if the physical state of the DNA in newborns could reflect their underlying genetic risks.
The results showed some clear patterns. For schizophrenia, researchers found an association between genetic risk and cord blood markers at 246 different locations. For autism, they identified 8 specific locations linked to the condition. Interestingly, no such link was found for ADHD in this study. The researchers also found that the signals for these conditions were mostly distinct from one another, meaning the biological markers for autism and schizophrenia appeared to be different.
When the researchers added these cord blood measurements into models used to predict developmental outcomes, they saw a small increase in how much of the variation in cognitive and motor skills could be explained. However, it is important to note that this increase was described as nominal. This means the improvement was small and might not be large enough to be considered a major change in prediction accuracy. It is important for families to keep these findings in perspective. While the study shows that certain markers are present in cord blood, it does not mean a diagnosis can be made from a single test. The results show an association with genetic risk, not a guarantee of a future condition. Because this was a large-scale analysis of many people, it provides a helpful map for scientists to study further, but it is not yet a tool for individual clinical use. For now, these findings offer a deeper look into how early life biology relates to long-term health.
